LAPELGA
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Apr 2021)
What this means for you
This application is over — abandoned 12 Apr 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88260489
- Mark type
- Stylized text
- Filed
- 14 Jan 2019
- Published for opposition
- 14 Jul 2020
- Abandoned
- 12 Apr 2021
- Attorney of record
- Sheryl De Luca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for hematopoietic growth factors; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production
Owner
- ACCORD BIOPHARMA, INC., DURHAM, NC, US
- Apotex Technologies Inc., Toronto, Ontario, CA
Prosecution history
- 12 Apr 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Apr 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Sept 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2020 — PUBLISHED FOR OPPOSITION
- 24 Jun 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jun 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 02 Jun 2020 — ASSIGNED TO LIE
- 26 May 2020 — ASSIGNED TO LIE
- 19 May 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 May 2020 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 15 Apr 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Mar 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 May 2019 — ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED